Breaking News

NanoBio, Merck Enter Adjuvant Technology Pact

By Kristin Brooks | March 26, 2014

Will use NanoStat platform for RSV and flu vaccine development

NanoBio Corp. has signed a licensing agreement with a subsidiary of Merck for the use of its nanoemulsion (NE) adjuvant technology for vaccine development.
 
Merck will have exclusive rights to NanoBio's NE adjuvant for use in an intranasal respiratory syncytial virus (RSV) vaccine and non-exclusive rights for use in an intranasal seasonal flu and/or universal seasonal flu vaccine. NanoBio will receive an upfront payment and is eligible to receive development and regulatory milestones, as well as royalties on sales of any Merck RSV or flu vaccines that use the NE adjuvant technology.
 
The NanoStat technology platform employs a novel oil-in-water nanoemulsion that can incorporate, deliver and adjuvant multiple antigen types, which, according to the company, is effective when administered via intranasal, intramuscular or subcutaneous vaccination.
 
"We've collaborated with Merck on research in RSV since 2011 and are very pleased to broaden our relationship with this license agreement covering vaccine candidates for two respiratory diseases," said David Peralta, chief executive officer of NanoBio. "Merck's demonstrated leadership in developing and marketing vaccines makes them an ideal partner for NanoBio."

Related Packaging:

Related Contract Manufacturing:

blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.